Relationship between serum endothelin-1 level and spontaneous reperfusion in patients with acute myocardial infarction

Coronary Artery Disease

Volumn 26, Issue 1, 2016, Pages 37-41

  Kilickesmez, Kadriye Orta ^a   Bingöl, Gülsüm ^a   Bulut, Leyla ^b   Sinan, Ümit Yaşar ^a   Abaci, Okay ^a   Ersanli, Murat ^a   Gurmen, Tevfik ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

endothelin; spontaneous reperfusion; ST segment elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENDOTHELIN 1; BIOLOGICAL MARKER;

ADULT; ANGIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CATHETERIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VEIN; PREDICTOR VARIABLE; PROTEIN BLOOD LEVEL; PUNCTURE; RECEIVER OPERATING CHARACTERISTIC; REPERFUSION; SPONTANEOUS REPERFUSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; ANGIOCARDIOGRAPHY; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RADIOGRAPHY; RISK; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; TURKEY;

ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; BIOMARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIN-1; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 84918834200     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000175     Document Type: Article

References (29)

1. OGara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American HeartAssociation Task Force on Practice Guidelines. Circulation 2013; 127:e362-e425.
2. Lee CW, Hong MK, Lee JH, Yang HS, Kim JJ, Park SW, et al. Determinants and prognostic significance of spontaneous coronary recanalization in acute myocardial infarction. Am J Cardiol 2001; 87:951-954.
3. Rimar D, Crystal E, Battler A, Gottlieb S, Freimark D, Hod H, et al. Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction. Heart 2002; 88:352-356.
4. Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001; 104:636-641.
5. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
6. Zouki C, Baron C, Fournier A, Filep JG. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol 1999; 127:969-979.
7. López Farré A, Riesco A, Espinosa G, Digiuni E, Cernadas MR, Alvarez V, et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993; 88:1166-1171.
8. Hayasaki Y, Nakajima M, Kitano Y, Iwasaki T, Shimamura T, Iwaki K. ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specific endothelin receptor subtype. Biochem Biophys Res Commun 1996; 229:817-824.
9. Lüscher TF, Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 2000; 102:2434-2440.
10. Tønnessen T, Naess PA, Kirkebøen KA, Offstad J, Ilebekk A, Christensen G. Release of endothelin from the porcine heart after short term coronary artery occlusion. Cardiovasc Res 1993; 27:1482-1485.
11. Wang QD, Hemsén A, Li XS, Lundberg JM, Uriuda Y, Pernow J. Local overflow and enhanced tissue content of endothelin following myocardial ischaemia and reperfusion in the pig:modulation by L-arginine. Cardiovasc Res 1995; 29:44-49.
12. Kolettis TM, Barton M, Langleben D, Matsumura Y. Endothelin in coronary artery disease and myocardial infarction. Cardiol Rev 2013; 21:249-256.
13. TIMI Study Group. Definitions used in TIMI trials. Available at: http://www. timi.org. [Accessed 22 January 2008].
14. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 2001; 103:2550-2554.
15. Iwakura K, Ito H, Kawano S, Okamura A, Asano K, Kuroda T, et al. Detection of TIMI-3 flow before mechanical reperfusion with ultrasonic tissue characterization in patients with anterior wall acute myocardial infarction. Circulation 2003; 107:3159-3164.
16. Kurowski V, Giannitsis E, Killermann DP, Wiegand UK, Toelg R, Bonnemeier H, et al. The effects of facilitated primary PCI by guide wire on procedural and clinical outcomes in acute ST-segment elevation myocardial infarction. Clin Res Cardiol 2007; 96:557-565.
17. Fefer P, Hod H, Hammerman H, Boyko V, Behar S, Matetzky S. Acute Coronary Syndrome Israeli Survey (ACSIS) 2006 Study Group. Relation of clinically defined spontaneous reperfusion to outcome in ST-elevation myocardial infarction. Am J Cardiol 2009; 103:149-153.
18. Stewart DJ, Kubac G, Costello KB, Cernacek P. Increased plasma endothelin-1 in early hours of acute myocardial infarction. J Am Coll Cardiol 1991; 18:38-43.
19. Lechleitner P, Genser N, Mair J, Maier J, Artner-Dworzak E, Dienstl F, et al. Endothelin-1 in patients with complicated and uncomplicated myocardial infarction. Clin Investig 1992; 70:1070-1072.
20. Kelly RF, Hursey TL, Schaer GL, Piotrowski MJ, Dee SV, Parrillo JE, et al. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion. J Investig Med 1996; 44:575-582.
21. Velasco CE, Turner M, Inagami T, Atkinson JB, Virmani R, Jackson EK, et al. Reperfusion enhances the local release of endothelin after regional myocardial ischemia. Am Heart J 1994; 128:441-451.
22. Filep JG, Foldes-Filep E, Rousseau A, Fournier A, Sirois P, Yano M. Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. Eur J Pharmacol 1992; 219:343-344.
23. Tamareille S, Terwelp M, Amirian J, Felli P, Zhang XQ, Barry WH, et al. Endothelin-1 release during the early phase of reperfusion is a mediator of myocardial reperfusion injury. Cardiology 2013; 125:242-249.
24. Niccoli G, Lanza GA, Shaw S, Romagnoli E, Gioia D, Burzotta F, et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. Eur Heart J 2006; 27:1793-1798.
25. Yip HK, Wu CJ, Chang HW, Yang CH, Yu TH, Chen YH, et al. Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty. Chest 2005; 127:1491-1497.
26. Katayama T, Yano K, Nakashima H, Takagi C, Honda Y, Suzuki S, et al. Clinical significance of acute-phase endothelin-1 in acute myocardial infarction patients treated with direct coronary angioplasty. Circ J 2005; 69:654-658.
27. Brener SJ, Mehran R, Brodie BR, Guagliumi G, Witzenbichler B, Cristea E, et al. Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials). Am J Cardiol 2011; 108:918-923.
28. Cremer P, Nagel D, Labrot B, Mann H, Muche R, Elster H, et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective gottingen risk incidence and prevalence study (GRIPS). Eur J Clin Invest 1994; 24:444-453.
29. Tcheng JE, Kandzari DE, Grines CL, Cox DA, Effron MB, Garcia E, et al. CADILLAC Investigators. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. Circulation 2003; 108:1316-1323.